A Phase 3, Multi-Site, Open-Label Study of the Long Term

Project: Research project

Project Details

Description

A Phase 3, Multi-Site, Open-Label Study of the Long Term Safety and Tolerability of 2 Oral Doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis
StatusFinished
Effective start/end date1/7/116/30/16

Funding

  • PFIZER, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.